Possible contribution of β-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells

Investigational New Drugs

Volumn 28, Issue 3, 2010, Pages 306-317

  Arafa, Hossam M M ^a  

^a Al Azhar University   (Egypt)

Author keywords

Apoptosis; Caco 2; Caspase 3; Caspase 9; Curcumin glucoside; Cytotoxicity; Diethylstilbesterol galactoside; Diethylstilbesterol glucoside; Glycoconjugates; HT29; Perillyl alcohol galactoside; Perillyl alcohol glucoside; T84

Indexed keywords

BETA GALACTOSIDASE; BETA GLUCOSIDASE; CASPASE; CASPASE 3; CASPASE 9; CURCUMIN BETA GLUCOSIDE; DIETHYLSTILBESTROL BETA GALACTOSIDE; DIETHYLSTILBESTROL BETA GLUCOSIDE; ESTERASE; GLYCOCONJUGATE; GLYCOSIDASE; PERILLYLALCOHOL BETA GALACTOSIDE; PERILLYLALCOHOL BETA GLUCOSIDE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION;

APOPTOSIS; BETA-GALACTOSIDASE; BETA-GLUCOSIDASE; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; ESTERASES; GLYCOCONJUGATES; HUMANS; KINETICS; LIPASE; MOLECULAR STRUCTURE; PRODRUGS;

EID: 77952242741     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-009-9248-2     Document Type: Article

References (40)

1. RV Chari 2008 Targeted cancer therapy: conferring specificity to cytotoxic drugs Acc Chem Res 41 98 107 10.1021/ar700108g 10.1021/ar700108g 1:CAS:528:DC%2BD2sXpt12isLo%3D 17705444
2. J Wu Y Lu A Lee X Pan X Yang X Zhao RJ Lee 2007 Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil J Pharm Pharm Sci 10 350 357 1:CAS:528:DC%2BD2sXptlKrtLo%3D 17727798
3. SM Deyev EN Lebedenko 2008 Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design Bioessays 30 904 918 10.1002/bies.20805 10.1002/bies.20805 1:CAS:528:DC%2BD1cXhtFGgsbrE 18693269
4. H Guan MJ McGuire S Li KC Brown 2008 Peptide-targeted polyglutamic acid doxorubicin conjugates for the treatment of alpha(v) beta(6)-positive cancers Bioconjug Chem 19 1813 1821 10.1021/bc800154f 10.1021/bc800154f 1:CAS:528:DC%2BD1cXpvFykur8%3D 18710273
5. Y Gupta DV Kohli SK Jain 2008 Vitamin B12-mediated transport: a potential tool for tumor targeting of antineoplastic drugs and imaging agents Crit Rev Ther Drug Carrier Syst 25 347 379 1:CAS:528:DC%2BD1cXnvFegt7g%3D 18540842
6. CL Ma CL Hsu MH Wu CT Wu CC Wu JJ Lai YS Jou CW Chen S Yeh C Chang 2008 Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma Gastroenterology 135 947 955 10.1053/j.gastro.2008.05. 046 10.1053/j.gastro.2008.05.046 1:CAS:528:DC%2BD1cXhtFylsrjE 18639551
7. H Devalapally RS Navath V Yenamandra RR Akkinepally RK Devarakonda 2007 Beta-galactoside prodrugs of doxorubicin for application in antibody directed enzyme prodrug therapy/prodrug monotherapy Arch Pharm Res 30 723 732 10.1007/BF02977634 10.1007/BF02977634 1:CAS:528:DC%2BD2sXosV2lt74%3D 17679550
8. S Song D Liu J Peng Y Sun Z Li JR Gu Y Xu 2008 Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo Int J Pharm 363 155 161 10.1016/j.ijpharm.2008.07.012 10.1016/j.ijpharm.2008.07.012 1:CAS:528:DC%2BD1cXhtFegu7bO 18692120
9. CD Young SM Anderson 2008 Sugar and fat-that's where it's at: metabolic changes in tumors Breast Cancer Res 10 202 210 10.1186/bcr1852 10.1186/bcr1852 18304378
10. Y Hannun 1997 Apoptosis and the dilemma of cancer chemotherapy Blood 89 1845 1853 1:CAS:528:DyaK2sXhvVakurg%3D 9058703
11. H Weichert I Blechschmidt S Schröder H Ambrosius 1991 The MTT-assay as a rapid test for cell proliferation and cell killing: application to human peripheral blood lymphocytes (PBL) Allerg Immunol (Leipz) 37 139 144 1:CAS:528:DyaK38XhvFait7o%3D
12. P Li D Nijhawan I Budihardjo SM Srinivasula M Ahmad ES Alnemri X Wang 1997 Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 91 4 479 489 10.1016/S0092-8674(00) 80434-1 10.1016/S0092-8674(00)80434-1 1:CAS:528:DyaK2sXnsFGls70%3D 9390557
13. DW Nicholson A Ali NA Thornberry 1995 Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 376 37 43 10.1038/376037a0 10.1038/376037a0 1:CAS:528:DyaK2MXmvVGqu7k%3D 7596430
14. RW Chadwick JC Allison DL Talley SE George 1995 Possible errors in assay for beta-glycosidase activity Appl Environ Microbiol 61 820 822 1:CAS:528:DyaK2MXjsV2luro%3D 7574621
15. MM Bradford 1976 A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 10.1016/0003-2697(76) 90527-3 10.1016/0003-2697(76)90527-3 1:CAS:528:DyaE28XksVehtrY%3D 942051
16. J Pelisek S Armeanu S Nikol 2000 Evaluation of beta-galactosidase activity in tissue in the presence of blood J Vasc Res 37 585 593 10.1159/000054092 10.1159/000054092 1:CAS:528:DC%2BD3MXoslGlsw%3D%3D 11146413 (Pubitemid 32037634)
17. K Strebhardt A Ullrich 2008 Paul Ehrlich's magic bullet concept: 100 years of progress Nat Rev Cancer 8 473 480 10.1038/nrc2394 10.1038/nrc2394 1:CAS:528:DC%2BD1cXmt1Oksbw%3D 18469827 (Pubitemid 351752547)
18. EW Neuse 2008 Synthetic polymers as drug-delivery vehicles in medicine Metab Based Drugs 2008 469531
19. Y Singh M Palombo PJ Sinko 2008 Recent trends in targeted anticancer prodrug and conjugate design Curr Med Chem 15 1802 1826 10.2174/ 092986708785132997 10.2174/092986708785132997 1:CAS:528:DC%2BD1cXovFWnsbo%3D 18691040
20. MP Deonarain AA Epenetos 1994 Targeting enzymes for cancer therapy: old enzymes in new roles Br J Cancer 70 786 794 1:CAS:528:DyaK2MXitlKjt7w%3D 7947082
21. T Mizuma S Masubuchi S Awazu 1999 Intestinal absorption of acyclovir beta-glucoside: comparative study with acyclovir, guanosine, and kinetin beta-glucoside Pharm Res 16 69 73 10.1023/A:1018818728393 10.1023/A: 1018818728393 1:CAS:528:DyaK1MXmtlGmtw%3D%3D 9950281 (Pubitemid 29047459)
22. P Workman 1997 Towards intelligent anticancer drug screening in the post-genome era? Anticancer Drug Des 12 525 531 1:CAS:528:DyaK2sXntFKmt7g%3D 9365499
23. WS Stebbings GP Vinson MJ Farthing F Balkwill RF Wood 1989 Effect of steroid hormones on human colorectal adenocarcinoma xenografts, of known steroid-receptor status, in nude mice J Cancer Res Clin Oncol 115 439 444 10.1007/BF00393333 10.1007/BF00393333 1:STN:280:DyaK3c%2FjslWnsQ%3D%3D 2808482
24. S Bardon V Foussard S Fournel A Loubat 2002 Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression Cancer Lett 181 187 194 10.1016/S0304-3835(02) 00047-2 10.1016/S0304-3835(02)00047-2 1:CAS:528:DC%2BD38XjsFyhtLs%3D 12175534
25. A Chen J Xu AC Johnson 2006 Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1 Oncogene 25 278 287 16170359
26. EJ Theron CF Albrecht PB Kruger K Jenkins MJ van der Merwe 1994 beta-Glucosidase activity in fetal bovine serum renders the plant glucoside, hypoxoside, cytotoxic toward B16-F10-BL-6 mouse melanoma cells In Vitro Cell Dev Biol Anim 30A 2 115 119 10.1007/BF02631403 10.1007/BF02631403 1:CAS:528:DyaK2cXlsVyntLc%3D 8012653
27. H Seker B Bertram H Troster R Fisher M Trendelenburg M Wiessler 2000 Potential influence of β-glucosidases on in vitro cytotoxicity mediated by β-D-Glc-IPM (glufosfamide), a new tumor therapeutic agent Annu Meet Am Assoc Cancer Res 41 602
28. LC Lin LL Yang CJ Chou 2003 Cytotoxic naphthoquinones and plumbagic acid glucosides from Plumbago zeylanica Phytochemistry 62 4 619 622 10.1016/S0031-9422(02) 00519-8 10.1016/S0031-9422(02)00519-8 1:CAS:528:DC%2BD3sXmsVegsw%3D%3D 12560036
29. YL Qi F Liao CQ Zhao YD Lin MX Zuo 2005 Cytotoxicity, apoptosis induction, and mitotic arrest by a novel podophyllotoxin glucoside, 4DPG, in tumor cells Acta Pharmacol Sin 26 8 1000 1008 10.1111/j.1745-7254.2005.00148.x 10.1111/j.1745-7254.2005.00148.x 1:CAS:528:DC%2BD2MXoslGksb8%3D 16038635 (Pubitemid 41153223)
30. C Gauthier J Legault M Lebrun P Dufour A Pichette 2006 Glycosidation of lupane-type triterpenoids as potent in vitro cytotoxic agents Bioorg Med Chem 14 19 6713 6725 10.1016/j.bmc.2006.05.075 10.1016/j.bmc.2006.05.075 1:CAS:528:DC%2BD28XosVOiu74%3D 16787747 (Pubitemid 44233310)
31. KN Syrigos G Rowlinson-Busza AA Epenetos 1998 In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibody Int J Cancer 78 712 719 10.1002/(SICI) 1097-0215(19981209) 78:6<712::AID-IJC8>3.0.CO;2-D 10.1002/(SICI)1097-0215(19981209)78:6<712::AID-IJC8>3.0.CO;2-D 1:CAS:528:DyaK1cXotVCkt7o%3D 9833764
32. ADIS R&D PROFILE 2005 Glufosfamide: beta-D-Glc-IPM, D 19575 Drugs R D 6 49 52 10.2165/00126839-200506010-00006 10.2165/00126839-200506010-00006 (Pubitemid 40259730)
33. M de Graaf HM Pinedo R Quadir HJ Haisma E Boven 2003 Cytosolic beta-glycosidases for activation of glycoside prodrugs of daunorubicin Biochem Pharmacol 65 1875 1881 10.1016/S0006-2952(03) 00183-7 10.1016/S0006-2952(03) 00183-7 12781339
34. V Milacic S Banerjee KR Landis-Piwowar FH Sarkar AP Majumdar QP Dou 2008 Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo Cancer Res 68 7283 7292 10.1158/0008-5472.CAN-07-6246 10.1158/0008-5472.CAN-07-6246 1:CAS:528:DC%2BD1cXhtFWltLbK 18794115
35. L Yeruva KJ Pierre A Elegbede RC Wang SW Carper 2007 Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells Cancer Lett 257 216 226 10.1016/j.canlet.2007.07.020 10.1016/j.canlet.2007.07.020 1:CAS:528:DC%2BD2sXhtFGkt7nK 17888568 (Pubitemid 47538829)
36. Q Wang X Li L Wang YH Feng R Zeng G Gorodeski 2004 Antiapoptotic effects of estrogen in normal and cancer human cervical epithelial cells Endocrinology 145 5568 5579 10.1210/en.2004-0807 10.1210/en.2004-0807 1:CAS:528: DC%2BD2cXhtVaqu73F 15319352 (Pubitemid 39564597)
37. S Mazumder D Plesca A Almasan 2008 Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis Methods Mol Biol 414 13 21 10.1007/978-1-59745-339-4-2 1:CAS:528:DC%2BD2sXhtlerurjK 18175808
38. CR Johnson WD Jarvis 2004 Caspase-9 regulation: an update Apoptosis 9 4 423 427 10.1023/B:APPT.0000031457.90890.13 10.1023/B:APPT.0000031457.90890.13 1:CAS:528:DC%2BD2cXkslWqurk%3D 15192324 (Pubitemid 38987578)
39. H Devalapally KS Rajan RR Akkinepally RK Devarakonda 2008 Safety, pharmacokinetics and biodistribution studies of a beta-galactoside prodrug of doxorubicin for improvement of tumor selective chemotherapy Drug Dev Ind Pharm 34 789 795 10.1080/03639040701744202 10.1080/03639040701744202 18608462
40. M Nomoto K Yamada M Haga M Hayashi 1998 Improvement of intestinal absorption of peptide drugs by glycosylation: transport of tetrapeptide by the sodium ion-dependent D-glucose transporter J Pharm Sci 87 326 332 10.1021/js970269p 10.1021/js970269p 1:CAS:528:DyaK1cXovFOisQ%3D%3D 9523986 (Pubitemid 28204586)